Our analysis, in contrast, covers four larger patient cohorts (625 in total) with longer follow‐up data and, the prognostic value of B7‐H3 was also assessed in more uniformly treated AML patients with normal cytogenetics. This evidence concerns the gene CD276 and acute myeloid leukemia.